Cargando…
Dissecting the multifaceted impact of statin use on fatty liver disease: A multidimensional study
BACKGROUND: Statin use could benefit patients with non-alcoholic fatty liver disease (NAFLD), but the evidence is segmented and inconclusive. This multidimensional study comprehensively investigated the potential benefits and mechanism-of-action of statins in NAFLD. METHODS: A cross-sectional invest...
Autores principales: | Ayada, Ibrahim, van Kleef, Laurens A., Zhang, Huai, Liu, Kuan, Li, Pengfei, Abozaid, Yasir J., Lavrijsen, Marla, Janssen, Harry L.A., van der Laan, Luc J.W., Ghanbari, Mohsen, Peppelenbosch, Maikel P., Zheng, Ming-Hua, de Knegt, Robert J., Pan, Qiuwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758527/ https://www.ncbi.nlm.nih.gov/pubmed/36502575 http://dx.doi.org/10.1016/j.ebiom.2022.104392 |
Ejemplares similares
-
The Steatosis-associated fibrosis estimator (SAFE) score: validation in the general US population
por: van Kleef, Laurens A., et al.
Publicado: (2023) -
Metabolic dysfunction–associated fatty liver disease improves detection of high liver stiffness: The Rotterdam Study
por: van Kleef, Laurens A., et al.
Publicado: (2021) -
Differing pan-coronavirus antiviral potency of boceprevir and GC376 in vitro despite discordant molecular docking predictions
por: Wang, Yining, et al.
Publicado: (2022) -
Clinical Features, Antiviral Treatment, and Patient Outcomes: A Systematic Review and Comparative Analysis of the Previous and the 2022 Mpox Outbreaks
por: Li, Pengfei, et al.
Publicado: (2023) -
Serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) predict severity of liver disease in chronic hepatitis B
por: Li, Juan, et al.
Publicado: (2017)